Address And Details

100 Vanguard Blvd. , Malvern, PA 19355
Fund Manager Walter Nejman
Manager Tenure 5 Years 9 Months

Strategy And Objective

The Fund seeks to track the performance of a benchmark index that measures the investment return of health care stocks.The Fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard(GICS). The GICS health care sector includes health care provider and services companies, companies that manufacture and distribute health care equipment and supplies, and health care technology companies. It also includes companies involved in the research, development, production, and marketing of pharmaceuticals and biotechnology products.The Fund attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the Index, in order to hold each stock in approximately the same proportion as its weighting in the Index.

Net Asset Value

as of 5:34 PM ET 09/17/2021

Performance

  • 1 Week
  • -0.06%
  • 1 Month
  • -1.43%
  • 3 Months
  • +5.73%
  • 1 Yr Return
  • +27.38%
  • 5 Yr Return
  • +94.02%

Equity Sector Breakdown

Health 54.91%
Finance 12.45%
Services 8.91%
Technology 8.18%
IndustrialCyclical 7.48%
RetailTrade 1.43%
NonDurables 0.34%
ConsumerDurables n/a
Energy n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 99.92%
ForeignStocks 3.03%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 2.97 B

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 1.94 1.76 4.05
Beta 0.75 0.80 0.82
R Squared 0.73 0.69 0.67
Std Deviation 16.35 14.42 13.45
Sharpe Ratio 0.98 1.12 n/a

Purchase Information

as of 5:33 PM ET 09/16/2021
Minimum Initial $100000
Minimum Additional $1
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +28.01%
  • +29.87%
+28.01% +29.87%
3 Year
  • +15.80%
  • +17.63%
+15.80% +17.63%
10 Year
  • +17.72%
  • +16.16%
+17.72% +16.16%
Life Of Fund
  • +11.34%
  • +11.07%
+11.34% +11.07%

Top 10 Holdings

Symbol Company Name % Of Assets
JNJ JOHNSON & JOHNSON 7.77%
UNH UNITEDHEALTH GROUP INC 6.83%
PFE PFIZER INC 3.78%
ABT ABBOTT LABORATORIES 3.61%
ABBV ABBVIE INC 3.49%
MRK MERCK & CO INC 3.36%
TMO THERMO FISHER SCIENTIFIC INC 3.23%
MDT MEDTRONIC PLC 2.98%
DHR DANAHER CORP 2.87%
LLY ELI LILLY & CO 2.84%

Recent Articles from TheStreet

Nasdaq-listed Chinese Electric Carmaker Li Auto Apologises For Passing Off Recall Of 10,469 Li ONEs As 'upgrade' Offer

Chinese EV Maker Li Cuts Delivery Forecast, Shares Fall

Li trims its forecast to 24,500 vehicle deliveries for the third quarter from 25,000 to 26,000.

Toys 'R' Us Sells FAO Schwarz as it Reveals Further Debt Refinancing Plans

Toymakers Facing Holiday Challenge Due to Supply-Chain Issues

Supply-chain issues could make this Christmas season more challenging than normal for toymakers, a media report says.

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Twitter Blue Lead

Twitter to Pay $810M to Settle Holder Suit Over User Engagement

Twitter's payment would settle a shareholder lawsuit that the company misled investors about its user engagement totals.

Starboard Takes Stake in CVS Health Corp.: Report

CVS to Add 25,000 Workers Ahead of Flu Season, Covid Booster Shots

Pharmacy giant CVS plans to add 25,000 ahead of flu season and coronavirus-related vaccinations.

Chinese Investors Mock Asset Managers And Offer Advice On Stock Picks For Cautious Approach To Renewables Sector

Stocks May Drop 20% as Stimulus Eases, Growth Slows: Morgan Stanley

Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.

Cryptocurrency Lead

Cryptocurrency Price Check: Bitcoin Tumbles on Evergrande Woes

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.

China Aims To Strengthen Its Semiconductor Supply Chain With New Standards Group That Includes Huawei, SMIC

Brooks Automation Stock Jumps on Plan to Sell Chip Solutions Unit for $3B

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.

DR Horton, Verizon, HCA Holdings Top Analysts' Actions Monday

DR Horton Trims 2021 Sales Forecast Amid Supply Chain Disruptions

DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.

11. Colgate-Palmolive

Colgate-Palmolive Underappreciated, Deutsche Bank Says, Lifting to Buy

Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.